Effects of an NMDA antagonist on the auditory mismatch negativity response to transcranial direct current stimulation. (May 2017)

• Record Type: Journal Article
• Authors: Impey, Danielle; de la Salle, Sara; Baddeley, Ashley; Knott, Verner
• Is Part Of: Journal of psychopharmacology. Volume 31:Number 5(2017)
• Page Start: 614
• Page End: 624
• Publication Date: 2017-05
• Subjects: Transcranial direct current stimulation -- NMDA antagonist -- dextromethorphan -- mismatch negativity -- event-related potentials; Psychopharmacology -- Periodicals; 615.78
• DOI: 10.1177/0269881116665336
• Languages: English
• ISSNs: 0269-8811

Abstract

Transcranial direct current stimulation (tDCS) is a non-invasive form of brain stimulation which uses a weak constant current to alter cortical excitability and activity temporarily. tDCS-induced increases in neuronal excitability and performance improvements have been observed following anodal stimulation of brain regions associated with visual and motor functions, but relatively little research has been conducted with respect to auditory processing. Recently, pilot study results indicate that anodal tDCS can increase auditory deviance detection, whereas cathodal tDCS decreases auditory processing, as measured by a brain-based event-related potential (ERP), mismatch negativity (MMN). As evidence has shown that tDCS lasting effects may be dependent on N-methyl-D-aspartate (NMDA) receptor activity, the current study investigated the use of dextromethorphan (DMO), an NMDA antagonist, to assess possible modulation of tDCS's effects on both MMN and working memory performance. The study, conducted in 12 healthy volunteers, involved four laboratory test sessions within a randomised, placebo and sham-controlled crossover design that compared pre- and post-anodal tDCS over the auditory cortex (2 mA for 20 minutes to excite cortical activity temporarily and locally) and sham stimulation (i.e. device is turned off) during both DMO (50 mL) and placebo administration. Anodal tDCS increased MMN amplitudes with placebo administration. Significant increases were not seen with sham stimulation or with anodal stimulation during DMO administration. With sham stimulation (i.e. no stimulation), DMO decreased MMN amplitudes. Findings from this study contribute to the understanding of underlying neurobiological mechanisms mediating tDCS sensory and memory improvements.